news

COVID-19 pandemic to heighten sales of pharmaceutical spray drying

4
SHARES

A new report has predicted that the COVID-19 pandemic will drive demand for pharmaceutical spray drying, boosting the market.

Pharmaceutical spray drying

According to a new report, demand for pharmaceutical spray drying will increase due to the COVID-19 pandemic. The research was conducted by Persistence Market Research (PMR). 

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

The report outlines that pharmaceutical spray drying refers to a process of rapid drying of pharmaceutical product with hot gas to produce dry powder from liquid or slurry. This is a process typically used to enhance a drug’s bioavailability

In pharmaceutical spray drying, evenly sized particles are distributed for producing industrial products such as catalysts. Air is the most commonly used medium for drying; however, when liquid is inflammable, the ethanol can be used as a drying agent. If the product is oxygen sensitive, then nitrogen can be used. Pharmaceutical spray dryers use an atomiser or spray nozzle for easy dispersion of liquid or slurry into the area which has drying medium in it which results in powder formation. The process is most commonly used for production of active pharmaceutical ingredients (APIs).

The report says that the market is growing due to various desired characteristics offered such as enhanced bioavailability, no contamination, hygienic conditions and pressure control, properties that are ideal for medicine produced during the COVID-19 pandemic. The introduction of new drugs in the market, such as vaccines and biologics, that require spray drying technology for their production, are therefore expected to offer good opportunities for the market.

The researchers also highlight that North America dominates the global market for pharmaceutical spray drying, due to high demand for pharmaceutical products and technological advancement in the region. Europe, followed by the Asia, is expected to experience high growth rate in the next few years in global pharmaceutical spray drying market. This is due to improvement in the healthcare facilities and increasing R&D initiatives in the regions.

Countries such as Brazil, Russia, China and India are expected to be the fastest growing pharmaceutical spray drying markets. Some of the key driving forces for this market in emerging countries include rising standards of healthcare, government initiatives and a desire for enhanced bioavailability.

Related diseases & conditions

Share via
Share via